Blood Phenylalanine Concentrations in Patients with PAH-deficient Hyperphenylalaninaemia off Diet Without and with Three Different Single Oral Doses of Tetrahydrobiopterin: Assessing Responsiveness in a Model of Statistical Process Control

Overview

Journal J Inherit Metab Dis

Publisher Wiley

Date 2009 Jun 11

PMID 19513811

Citations 1

Authors

M Lindner

G Gramer

S F Garbade

P Burgard

Affiliations

Soon will be listed here.

Abstract

Tetrahydrobiopterin (BH(4)) cofactor loading is a standard procedure to differentiate defects of BH(4) metabolism from phenylalanine hydroxylase (PAH) deficiency. BH(4) responsiveness also exists in PAH-deficient patients with high residual PAH activity. Unexpectedly, single cases with presumed nil residual PAH activity have been reported to be BH(4) responsive, too. BH(4) responsiveness has been defined either by a >or=30% reduction of blood Phe concentration after a single BH(4) dose or by a decline greater than the individual circadian Phe level variation. Since both methods have methodological disadvantages, we present a model of statistical process control (SPC) to assess BH(4) responsiveness. Phe levels in 17 adult PKU patients of three phenotypic groups off diet were compared without and with three different single oral dosages of BH(4) applied in a double-blind randomized cross-over design. Results are compared for >or=30% reduction and SPC. The effect of BH(4) by >or=30% reduction was significant for groups (p < 0.01) but not for dose (p = 0.064), with no interaction of group with dose (p = 0.24). SPC revealed significant effects for group (p < 0.01) and the interaction for group with dose (p < 0.05) but not for dose alone (p = 0.87). After one or more loadings, seven patients would be judged to be BH(4) responsive either by the 30% criterion or by the SPC model, but only three by both. Results for patients with identical PAH genotype were not very consistent within (for different BH(4) doses) and between the two models. We conclude that a comparison of protein loadings without and with BH(4) combined with a standardized procedure for data analysis and decision would increase the reliability of diagnostic results.

Citing Articles

Tetrahydrobiopterin responsiveness after extended loading test of 12 Danish PKU patients with the Y414C mutation.

Nielsen J, Nielsen K, Guttler F J Inherit Metab Dis. 2010; 33(1):9-16.

PMID: 20063067 DOI: 10.1007/s10545-009-9002-0.

References

Weglage J, Funders B, Ullrich K, Rupp A, Schmidt E . Psychosocial aspects in phenylketonuria. Eur J Pediatr. 1996; 155 Suppl 1:S101-4. DOI: 10.1007/pl00014225. View

Zurfluh M, Giovannini M, Fiori L, Fiege B, Gokdemir Y, Baykal T . Screening for tetrahydrobiopterin deficiencies using dried blood spots on filter paper. Mol Genet Metab. 2005; 86 Suppl 1:S96-103. DOI: 10.1016/j.ymgme.2005.09.011. View

Leuzzi V, Carducci C, Chiarotti F, Artiola C, Giovanniello T, Antonozzi I . The spectrum of phenylalanine variations under tetrahydrobiopterin load in subjects affected by phenylalanine hydroxylase deficiency. J Inherit Metab Dis. 2006; 29(1):38-46. DOI: 10.1007/s10545-006-0096-3. View

Fiege B, Ballhausen D, Kierat L, Leimbacher W, Goriounov D, Schircks B . Plasma tetrahydrobiopterin and its pharmacokinetic following oral administration. Mol Genet Metab. 2004; 81(1):45-51. DOI: 10.1016/j.ymgme.2003.09.014. View

Niederwieser A, Curtius H, VISCONTINI M, Schaub J, Schmidt H . Phenylketonuria variants. Lancet. 1979; 1(8115):550. DOI: 10.1016/s0140-6736(79)90966-8. View

Lindner M, Steinfeld R, Burgard P, Schulze A, Mayatepek E, Zschocke J . Tetrahydrobiopterin sensitivity in German patients with mild phenylalanine hydroxylase deficiency. Hum Mutat. 2003; 21(4):400. DOI: 10.1002/humu.9117. View

Levy H, Burton B, Cederbaum S, Scriver C . Recommendations for evaluation of responsiveness to tetrahydrobiopterin (BH(4)) in phenylketonuria and its use in treatment. Mol Genet Metab. 2007; 92(4):287-91. DOI: 10.1016/j.ymgme.2007.09.017. View

Zurfluh M, Zschocke J, Lindner M, Feillet F, Chery C, Burlina A . Molecular genetics of tetrahydrobiopterin-responsive phenylalanine hydroxylase deficiency. Hum Mutat. 2007; 29(1):167-75. DOI: 10.1002/humu.20637. View

Guttler F, Azen C, Guldberg P, Romstad A, Hanley W, Levy H . Relationship among genotype, biochemical phenotype, and cognitive performance in females with phenylalanine hydroxylase deficiency: report from the Maternal Phenylketonuria Collaborative Study. Pediatrics. 1999; 104(2 Pt 1):258-62. DOI: 10.1542/peds.104.2.258. View

10.

Landis J, Koch G . The measurement of observer agreement for categorical data. Biometrics. 1977; 33(1):159-74. View

11.

Matalon R, Koch R, Michals-Matalon K, Moseley K, Surendran S, Tyring S . Biopterin responsive phenylalanine hydroxylase deficiency. Genet Med. 2004; 6(1):27-32. DOI: 10.1097/01.gim.0000108840.17922.a7. View

12.

Fiege B, Bonafe L, Ballhausen D, Baumgartner M, Thony B, Meili D . Extended tetrahydrobiopterin loading test in the diagnosis of cofactor-responsive phenylketonuria: a pilot study. Mol Genet Metab. 2005; 86 Suppl 1:S91-5. DOI: 10.1016/j.ymgme.2005.09.014. View

13.

Fiori L, Fiege B, Riva E, Giovannini M . Incidence of BH4-responsiveness in phenylalanine-hydroxylase-deficient Italian patients. Mol Genet Metab. 2005; 86 Suppl 1:S67-74. DOI: 10.1016/j.ymgme.2005.06.017. View

14.

Niederwieser A, Ponzone A, Curtius H . Differential diagnosis of tetrahydrobiopterin deficiency. J Inherit Metab Dis. 1985; 8 Suppl 1:34-8. DOI: 10.1007/BF01800657. View

15.

Desviat L, Perez B, Belanger-Quintana A, Castro M, Aguado C, Sanchez A . Tetrahydrobiopterin responsiveness: results of the BH4 loading test in 31 Spanish PKU patients and correlation with their genotype. Mol Genet Metab. 2004; 83(1-2):157-62. DOI: 10.1016/j.ymgme.2004.06.007. View

16.

Langenbeck U . Classifying tetrahydrobiopterin responsiveness in the hyperphenylalaninaemias. J Inherit Metab Dis. 2008; 31(1):67-72. DOI: 10.1007/s10545-007-0572-4. View

17.

Macdonald A . Diet and compliance in phenylketonuria. Eur J Pediatr. 2000; 159 Suppl 2:S136-41. DOI: 10.1007/pl00014375. View

18.

Muntau A, Roschinger W, Habich M, Demmelmair H, Hoffmann B, Sommerhoff C . Tetrahydrobiopterin as an alternative treatment for mild phenylketonuria. N Engl J Med. 2002; 347(26):2122-32. DOI: 10.1056/NEJMoa021654. View

19.

Burgard P, Bremer H, Buhrdel P, Clemens P, Monch E, Przyrembel H . Rationale for the German recommendations for phenylalanine level control in phenylketonuria 1997. Eur J Pediatr. 1999; 158(1):46-54. DOI: 10.1007/s004310051008. View

20.

Gramer G, Garbade S, Blau N, Lindner M . Pharmacokinetics of tetrahydrobiopterin following oral loadings with three single dosages in patients with phenylketonuria. J Inherit Metab Dis. 2008; 32(1):52-7. DOI: 10.1007/s10545-008-0955-1. View